9-122849691-A-C
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 0P and 4B. BS2
The NM_001100588.3(RC3H2):āc.3512T>Gā(p.Val1171Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000143 in 1,613,690 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/23 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001100588.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RC3H2 | NM_001100588.3 | c.3512T>G | p.Val1171Gly | missense_variant | 21/21 | ENST00000357244.7 | NP_001094058.1 | |
RC3H2 | NM_001354482.2 | c.3398T>G | p.Val1133Gly | missense_variant | 20/20 | NP_001341411.1 | ||
RC3H2 | NM_001354479.2 | c.3341T>G | p.Val1114Gly | missense_variant | 20/20 | NP_001341408.1 | ||
RC3H2 | NM_001354478.2 | c.*103T>G | 3_prime_UTR_variant | 21/21 | NP_001341407.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152110Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000160 AC: 4AN: 249252Hom.: 0 AF XY: 0.0000148 AC XY: 2AN XY: 135280
GnomAD4 exome AF: 0.0000144 AC: 21AN: 1461580Hom.: 0 Cov.: 31 AF XY: 0.0000206 AC XY: 15AN XY: 727100
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152110Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74294
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 24, 2024 | The c.3512T>G (p.V1171G) alteration is located in exon 21 (coding exon 20) of the RC3H2 gene. This alteration results from a T to G substitution at nucleotide position 3512, causing the valine (V) at amino acid position 1171 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at